These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 11103806
21. Metabolism and action of fludarabine phosphate. Plunkett W, Huang P, Gandhi V. Semin Oncol; 1990 Oct; 17(5 Suppl 8):3-17. PubMed ID: 1699280 [Abstract] [Full Text] [Related]
22. Action of 9-beta-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism. Huang P, Plunkett W. Mol Pharmacol; 1991 Apr; 39(4):449-55. PubMed ID: 1708088 [Abstract] [Full Text] [Related]
23. Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes. Sandoval A, Consoli U, Plunkett W. Clin Cancer Res; 1996 Oct; 2(10):1731-41. PubMed ID: 9816124 [Abstract] [Full Text] [Related]
24. c-Jun-NH2-terminal kinase potentiates apoptotic cell death in response to carboplatin in B lymphoma cells. Takada E, Hata K, Mizuguchi J. Cancer Chemother Pharmacol; 2008 Sep; 62(4):569-76. PubMed ID: 18026729 [Abstract] [Full Text] [Related]
25. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA. Grant S, Jarvis WD, Swerdlow PS, Turner AJ, Traylor RS, Wallace HJ, Lin PS, Pettit GR, Gewirtz DA. Cancer Res; 1992 Nov 15; 52(22):6270-8. PubMed ID: 1423273 [Abstract] [Full Text] [Related]
26. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis. Wang Z, Van Tuyle G, Conrad D, Fisher PB, Dent P, Grant S. Cancer Res; 1999 Mar 15; 59(6):1259-67. PubMed ID: 10096557 [Abstract] [Full Text] [Related]
27. Increased p21/WAF-1 and p53 protein levels following sequential three drug combination regimen of fludarabine, cytarabine and docetaxel induces apoptosis in human leukemia cells. Avramis VI, Nandy P, Kwock R, Solorzano MM, Mukherjee SK, Danenberg P, Cohen LJ. Anticancer Res; 1998 Mar 15; 18(4A):2327-38. PubMed ID: 9703875 [Abstract] [Full Text] [Related]
28. Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells. Gandhi V, Plunkett W. Cancer Res; 1988 Jan 15; 48(2):329-34. PubMed ID: 3335008 [Abstract] [Full Text] [Related]
29. c-Myc potentiates the mitochondrial pathway of apoptosis by acting upstream of apoptosis signal-regulating kinase 1 (Ask1) in the p38 signalling cascade. Desbiens KM, Deschesnes RG, Labrie MM, Desfossés Y, Lambert H, Landry J, Bellmann K. Biochem J; 2003 Jun 01; 372(Pt 2):631-41. PubMed ID: 12646044 [Abstract] [Full Text] [Related]
30. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells. Bullock G, Ray S, Reed J, Miyashita T, Maria Ibrado A, Huang Y, Bhalla K. Clin Cancer Res; 1995 May 01; 1(5):559-64. PubMed ID: 9816016 [Abstract] [Full Text] [Related]
31. Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review). Van den Neste E, Cardoen S, Offner F, Bontemps F. Int J Oncol; 2005 Oct 01; 27(4):1113-24. PubMed ID: 16142330 [Abstract] [Full Text] [Related]
32. Arabinosylguanine-induced apoptosis of T-lymphoblastic cells: incorporation into DNA is a necessary step. Rodriguez CO, Gandhi V. Cancer Res; 1999 Oct 01; 59(19):4937-43. PubMed ID: 10519407 [Abstract] [Full Text] [Related]
33. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines. Avramis IA, Laug WE, Sausville EA, Avramis VI. Cancer Chemother Pharmacol; 2003 Oct 01; 52(4):307-18. PubMed ID: 12827297 [Abstract] [Full Text] [Related]
34. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C. Grant S, Turner AJ, Bartimole TM, Nelms PA, Joe VC, Jarvis WD. Oncol Res; 1994 Oct 01; 6(2):87-99. PubMed ID: 7949469 [Abstract] [Full Text] [Related]
35. Activation of c-Jun N-terminal kinase 1 and caspase 3 in the tamoxifen-induced apoptosis of rat glioma cells. Tseng SH, Wang CH, Lin SM, Chen CK, Huang HY, Chen Y. J Cancer Res Clin Oncol; 2004 May 01; 130(5):285-93. PubMed ID: 14997384 [Abstract] [Full Text] [Related]
36. c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. Seimiya H, Mashima T, Toho M, Tsuruo T. J Biol Chem; 1997 Feb 14; 272(7):4631-6. PubMed ID: 9020192 [Abstract] [Full Text] [Related]
37. Activation of c-Jun N-terminal kinase 1 (JNK1) in mistletoe lectin II-induced apoptosis of human myeloleukemic U937 cells. Park R, Kim MS, So HS, Jung BH, Moon SR, Chung SY, Ko CB, Kim BR, Chung HT. Biochem Pharmacol; 2000 Dec 01; 60(11):1685-91. PubMed ID: 11077051 [Abstract] [Full Text] [Related]
38. In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis. Kano Y, Akutsu M, Tsunoda S, Suzuki K, Ichikawa A, Furukawa Y, Bai L, Kon K. Leukemia; 2000 Mar 01; 14(3):379-88. PubMed ID: 10720130 [Abstract] [Full Text] [Related]
39. Role of c-Jun N-terminal kinase/p38 stress signaling in 1-beta-D-arabinofuranosylcytosine-induced apoptosis. Stadheim TA, Saluta GR, Kucera GL. Biochem Pharmacol; 2000 Feb 15; 59(4):407-18. PubMed ID: 10644049 [Abstract] [Full Text] [Related]
40. Use of novel plasmid constructs to demonstrate fludarabine triphosphate inhibition of nucleotide excision repair of a site-specific 1,2-d(GpG) intrastrand cisplatin adduct. Li MJ, Yang LY. Int J Oncol; 1999 Dec 15; 15(6):1177-83. PubMed ID: 10568825 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]